CareFusion’s spin-off from Cardinal Health set for mid-year
This article was originally published in The Gray Sheet
Executive Summary
Cardinal Health will spin off its clinical and medical products businesses - representing $4 billion in annual sales - by mid-year, according to the company. Given the name "CareFusion" on Feb. 16, the spin-off entity will include Alaris infusion pumps, Avea respirators, Pyxis medication dispensing systems, the MedMined electronic infection surveillance service, and ChloraPrep skin preparation products. The new firm will be based in San Diego, have 13,000 employes, and is expected to trade on the New York Stock Exchange under the symbol "CFN." The spin-off has been in the works since last summer (1"The Gray Sheet" Aug. 11, 2008, In Brief)
You may also be interested in...
Cardinal spin-off?
Cardinal Health is weighing the possibility of spinning off its $5.6 billion clinical and medical products business as a separate, publicly traded company, the firm said Aug. 7. Last month, Cardinal consolidated its two major business activities of health care product sales and its $80 billion distributor operation into two distinct business units and cut 600 jobs (1"The Gray Sheet" July 21, 2008, In Brief). The clinical and medical products business includes Alaris infusion pumps, Avea respirators, Pyxis medication dispensing system, surgical gowns and gloves
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.